Christian Thiry has been appointed chief financial officer at Novasep. Mr. Thiry has 30 years of audit and finance executive management experience in the life sciences. For the past 12 years he served as chief financial officer and group executive committee member of Stallergenes, a biopharma company, where he helped expand the business, grow market capitalization, and increase profits.
“I am delighted to welcome Christian to Novasep’s executive team. This is a key appointment for Novasep as we continue to strengthen our core team which will be critical to driving our future growth,” said Michel Spagnol, chief executive officer, Novasep. “Christian’s broad experience is a major addition to the management team”. We would also like to thank Helen Lee Bouygues for her work as interim CFO to date and her continued support of the company during transition.”
Novasep has recently made investments in Mourenx, France, to build a large chromatography plant dedicated to the pharmaceutical industry; in Le Mans, France, to expand manufacturing capabilities of anti-cancer therapies; and in Shanghai, China, to better serve clients in Asia.